Knowledge Center

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as fi...

London, UK, and Durham (NC), US – June 24th, 2025: Phastar, a global specialist biometrics & data science Contrac...

London, UK, and Durham (NC), US – April 10th, 2025: Phastar, a global specialist biometrics & data science Contra...

We are excited to be presenting at PharmaSUG in Shanghai, 24-25 July 2026 Design and Analysis of a Multi-Frequency PR...

Phastar is delighted to be attending JSM 2026, 1-6 August in Boston, MA Connect to meet with our team on site or join...

Phastar is exhibiting at Medidata NEXT, 3 September 2026 in Shanghai, China Connect to meet with our team on site or ...

About This Webinar Bayesian methods continue to gain momentum as an alternative approach to traditional clinical tria...

About This Webinar Drug development in rare diseases requires the most efficient use of limited data, across both cli...

Join us for a transformative three-part webinar series, “Driving Clinical Research with AI,” where indust...

Phastar partnered with a biotechnology sponsor to manage statistical and data management activities for a late-stage ...

Discover how Phastar converted 16 legacy studies into SDTM and delivered a robust Integrated Summary of Safety (ISS) ...

A sponsor needed to pool data from four MS spasticity studies—one still ongoing with another vendor—while adapting mi...

To mark Clinical Trials Day 2026, Matt George, Senior Statistician, and Sam Hinsley, Statistics Manager at Phastar, h...

To mark Clinical trials day 2026, in a video interview for Applied Clinical Trials, Sam Hinsley, statistics manager a...

Sarah Tucker, Chief Operational Officer at Phastar, explores the evolution of Functional Service Provider (FSP) model...

In our “Meet the Team” series, we highlight the talented individuals who drive Phastar’s success. Each te...

Clinical trials are inherently complex, with risks emerging across data quality, patient safety, site perfo...

Understanding cause and effect is often of interest when conducting research, but in practice it is rarely ...

Early-phase oncology combination trials often assume the optimal dose is already included in the dosing gri...

As the pharmaceutical landscape evolves, traditional clinical trial designs are increasingly complemented by innovati...

Discover how Bayesian statistics can enhance clinical trial efficiency and improve decision-making. Our latest white ...